Although the mechanism of neutropenia associated with tocilizumab is unknown, up-to-date blocking of IL-6 in has an effect on neutrophil recruitment from bone marrow and in the regulation of its selection and expression, but the proposed mechanisms have no effects on the neutrophils function [13,14]. Here, IL6 is linked to neutropenia.